Smartlab Europe

Press Releases

Prestigious new Director will help PrescQIPP continue to deliver medicines optimisation opportunities and value for money to the NHS

PrescQIPP celebrates its first decade of helping commissioners to ensure that thousands of NHS patients get the best medicines for their condition, whilst saving the NHS millions by providing evidence-based expertise and advice on the prescribing and use of...

Sharp implements cloud-based QMS and strengthens quality leadership

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has rolled out the first phase of its new Quality Management System (QMS), Veeva QualityOne. QualityOne is a full suite QMS which will be...

Turkish Cargo carries COVID-19 vaccines via its cross-continental air bridge

Continuing its contributions for the sustainability of the global supply chain by building a global air cargo bridge all across the globe with its cargo flights, Turkish Cargo started to carry COVID-19 vaccines with its strong fleet, wide flight...

IATA addresses vaccine transportation challenges with new guidance

IATA has published guidance for the air cargo industry to follow when transporting Covid-19 vaccines to ensure that they are moved safely and securely in what it says is the “largest and most complex global logistics operation ever undertaken”. The...

BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China

BioNTech SE and Shanghai Fosun Pharmaceutical announced that the China National Medical Products Administration has approved the clinical trial in Mainland China for their mRNA vaccine candidate, BNT162b2. Wu Yifang, Chairman and CEO of Fosun Pharma, said: “As the ultimate...

Eisai receives approval for indication expansion of anti-epileptic agent fycompa for use in pediatric patients

Eisai Co., Ltd. announced that it has been received approval from the European Commission for the use of its in-house discovered and developed anti-epileptic agent (AED) Fycompa® (generic name: perampanel) in the treatment of pediatric patients. This approval extends...

CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Suitable for Standard Fridge Temperature Logistics

CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced that its mRNA-based COVID-19 vaccine candidate, CVnCoV, remained stable and within defined specifications for at least three months when stored...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »